- Report
- December 2023
- 80 Pages
Russia
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Japan
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1422EUR$1,500USD£1,188GBP
Lumefantrine is an antimalarial drug used to treat and prevent malaria. It is a combination of two active ingredients, lumefantrine and artemether, and is available in both oral and injectable forms. Lumefantrine is used in combination with other antimalarial drugs to treat uncomplicated Plasmodium falciparum malaria, a type of malaria caused by a parasite. It is also used to prevent malaria in people who are at risk of contracting the disease. Lumefantrine is effective against both chloroquine-resistant and multi-drug resistant strains of malaria.
Lumefantrine is a key component of many antimalarial drug combinations, and is widely used in the treatment of infectious diseases. It is available in many countries, and is often used in combination with other antimalarial drugs to treat malaria.
Companies in the Lumefantrine market include Novartis, Sanofi, GlaxoSmithKline, Cipla, and Ranbaxy. Show Less Read more